Ph2 clinical trial with paclitaxel in patients with endometrial cancer

Phase II Clinical Trial

FTH-PIK-201:A Randomized Open-label Multi-Center Phase 2 Clinical Trial Evaluating Sapanisertib and Serabelisib (PIKTOR) with Paclitaxel Serabelisib with Paclitaxel and Paclitaxel Alone in Patients with Advanced or Recurrent Endometrial Cancer

Indication: Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer
Trial Number: 06463028
Trial Status: OPEN

Learn more about this clinical trial.

Participating Locations